Bicycle Therapeutics director sells shares to cover taxes
Alpha Vantage · Kalkine Media · · AI-summarised by FinFlash
Bicycle Therapeutics PLC (NASDAQ: BCYC) Director Robert Charles Swanton sold 3,431 ordinary shares on October 2, 2026, according to a filing. The transaction was a mandatory sell-to-cover tied to statutory tax withholding obligations on vesting restricted stock units, not a discretionary sale. The shares were sold at a weighted average price of $3.47. Swanton directly holds 15,782 ordinary shares following the sale.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.